Answers are grounded in this paper and cite their sources.
Multiomic profiling uncovers transcriptional regulators in human Tr1 cells, suggesting therapeutic applications.
Type 1 regulatory T (Tr1) cells are CD4 + T cells with suppressive function that are induced from conventional T cells exposed to persistent or strong antigens. Human Tr1 cells are understudied; the regulators of their antigen-driven differentiation are unknown, and identifying them in tissues, where antigen interactions occur, is challenging. Here, we conducted a multiomic profiling of human antigen-induced Tr1 cells. Using CRISPR-based functional genomics, we uncovered essential roles of transcription factors IRF4, BATF, and MAF in human Tr1 differentiation, phenotype, and function. We also derived a Tr1 transcriptional signature that detects cells with a Tr1 phenotype in single-cell datasets from patients treated with Tr1 therapy and those with solid tumors. Cross-species analysis confirmed this signature identifies bona fide Tr1 cells induced in vivo in a murine solid tumor model. These findings provide a framework for development of Tr1-based and Tr1-targeting therapies and studies of Tr1 cell biology.
No takes yet. Share an insight, caveat, or question.
Cepika et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: